These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35132573)

  • 1. Population Norms for SF-6Dv2 and EQ-5D-5L in China.
    Xie S; Wu J; Xie F
    Appl Health Econ Health Policy; 2022 Jul; 20(4):573-585. PubMed ID: 35132573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
    Xie S; Wang D; Wu J; Liu C; Jiang W
    Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.
    Xie S; Wu J; Chen G
    Eur J Health Econ; 2024 Feb; 25(1):7-19. PubMed ID: 36709458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China.
    Xie S; Li M; Wang D; Hong T; Guo W; Wu J
    Health Qual Life Outcomes; 2023 Oct; 21(1):118. PubMed ID: 37904216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China.
    Guo W; Xie S; Wang D; Wu J
    Qual Life Res; 2024 Mar; 33(3):817-829. PubMed ID: 38167749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EQ-5D-5L and SF-6Dv2 health utilities scores of diffuse large B-cell lymphoma patients in China.
    Li M; Fang B; Gu H; Jiang Y
    Health Qual Life Outcomes; 2024 Sep; 22(1):80. PubMed ID: 39300432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China.
    Ding N; Zhou H; Chen C; Chen H; Shi Y
    Appl Health Econ Health Policy; 2024 Jul; 22(4):555-568. PubMed ID: 38641755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students.
    Zhou HJ; Zhang A; Wei J; Wu J; Luo N; Wang P
    BMC Public Health; 2023 Nov; 23(1):2314. PubMed ID: 37993793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China.
    Zhang A; Li J; Mao Z; Wang Z; Wu J; Luo N; Liu P; Wang P
    Eur J Health Econ; 2024 Dec; 25(9):1471-1484. PubMed ID: 38451345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EQ-5D-5L norms for the urban Chinese population in China.
    Yang Z; Busschbach J; Liu G; Luo N
    Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Zealand Population Norms for the EQ-5D-5L Constructed From the Personal Value Sets of Participants in a National Survey.
    Sullivan T; Turner RM; Derrett S; Hansen P
    Value Health; 2021 Sep; 24(9):1308-1318. PubMed ID: 34452711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec.
    Poder TG; Wang L; Carrier N
    BMJ Open; 2020 Sep; 10(9):e035722. PubMed ID: 32933957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples.
    Jiang R; Janssen MFB; Pickard AS
    Qual Life Res; 2021 Mar; 30(3):803-816. PubMed ID: 33025373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
    Nikl A; Janssen MF; Jenei B; Brodszky V; Rencz F
    Pharmacoeconomics; 2024 May; 42(5):583-603. PubMed ID: 38416366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canada population norms for the EQ-5D-5L.
    Yan J; Xie S; Johnson JA; Pullenayegum E; Ohinmaa A; Bryan S; Xie F
    Eur J Health Econ; 2024 Feb; 25(1):147-155. PubMed ID: 36828968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease.
    Xu RH; Luo N; Dong D
    Eur J Health Econ; 2024 Dec; 25(9):1505-1515. PubMed ID: 38472723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life among Indian population: The EQ-5D population norms for India.
    Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A
    J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems.
    Poder TG; Carrier N; Kouakou CRC
    Value Health; 2020 Feb; 23(2):251-259. PubMed ID: 32113631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.